CLL Support Association
8,951 members14,296 posts

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukemia: a single-arm, phase 2 study

I am not sure if you need to pay to view the whole article.

This article can be found in the following collections: Oncology (Haematological cancer)

Published Online: 21 August 2014

You may also like...